← Back to all substances
N

sertraline

174ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

INDICATIONS AND USAGE Major Depressive Disorder – Sertraline hydrochloride is indicated for the treatment of major depressive disorder in adults. The efficacy of Sertraline hydrochloride in the treatment of a major depressive episode was established in six to eight week controlled trials of adult ou...

Known as: Sertraline Hydrochloride
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
136,556
Total in FDA
85%
Serious Reports
73
Fatal Outcomes

Seriousness

Serious
424
Non-Serious
76

Sex Distribution

Male
162
Female
317
Unknown
21

Age Distribution

0-17
27
18-40
128
41-64
157
65-84
86
85+
9
Unknown
93

Outcomes

Recovered/Resolved
352
Recovering/Resolving
137
Not Recovered/Not Resolved
478
Recovered with Sequelae
48
Fatal
73
Unknown
1006

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-43aa97
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...